← Back to headlines
Aprea Therapeutics GAAP EPS of -$0.32 beats by $0.07
Aprea Therapeutics reported a GAAP EPS of -$0.32, surpassing analyst estimates by $0.07 for the recent financial period.
16 Mar, 12:53 — 16 Mar, 12:53
Sources
Showing 1 of 1 sources
